Synmosa Biopharma Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Synmosa Biopharma Corp

Watchlist Manager

Watchlist

Price: 29.05 TWD Market Closed

Market Cap: NT$16B

S	Synmosa Biopharma Corp TPEX:4114	TW
P	PPC Ltd JSE:PPC	ZA

Profitability Summary

Synmosa Biopharma Corp's profitability score is 50/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

41%

Sustainable 3Y Average Gross Margin

43%

Declining Gross Margin

42% > 41%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

12% > 11%

Healthy Net Margin

12%

Sustainable 3Y Average Net Margin

13%

Net Margin is Increasing

12% > 12%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All

Hide

Collapse

50 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.